The fluorescence technique described here utilizes the electrostatic interaction between the polyanionic sites of glycosaminoglycans and the cationic dye Acridine Orange to analyse urinary glycosaminoglycans from patients suffering from mucopolysaccharidoses. The basis of the titration is the decrease in the fluorescence of free Acridine Orange that occurs when it is bound to polyanions. The effect of the presence of possible interfering materials such as salt, proteins and trace materials in urine was evaluated. This fluorescence technique is technically simple.
(Received 17 March 1978) The fluorescence technique described here utilizes the electrostatic interaction between the polyanionic sites of glycosaminoglycans and the cationic dye Acridine Orange to analyse urinary glycosaminoglycans from patients suffering from mucopolysaccharidoses. The basis of the titration is the decrease in the fluorescence of free Acridine Orange that occurs when it is bound to polyanions. The effect of the presence of possible interfering materials such as salt, proteins and trace materials in urine was evaluated. This fluorescence technique is technically simple.
Many techniques for the investigation and analysis of glycosaminoglycans in biological fluids have been developed. These include precipitation with cationic detergents, uronic acid assay, chromatography and the use of cationic dyes, which have been comprehensively reviewed and evaluated (Pennock, 1976) . Scott & Newton (1975) have recovered varying fractions of the 'total' excreted urinary acid glycosaminoglycans by varying the reagent and the conditions under which a reagent is used. However (Whiteman, 1973a,b) , some of these techniques are laborious, time-consuming and/or unreliable. The present paper describes an alternative technique, a fluorescence assay of glycosaminoglycans by using Acridine Orange.
In its free monomeric state, the cationic dye Acridine Orange exhibits a broad fluorescence with a maximum at approx. 530nm, and in its aggregated state a fluorescence with a maximum at approx. 630nm. Polyanions promote dye aggregation; this phenomenon gives rise to metachromatic and fluorescence changes. Such properties may be used to assay glycosaminoglycans in biological fluids. A similar technique has been utilized for the analysis of carrageenan (Cundall et al., 1973) . In the present paper the analysis of urinary glycosaminoglycans is described, including its use in the diagnosis and monitoring of mucopolysaccharidoses. Acridine Orange (Sigma) was purified by a method previously outlined (Lamm & Neville, 1965) : an absorption coefficient (e492) of 5OOOM-1 cm-' was obtained for a 20uM aqueous solution (Bradley & Wolf, 1959 (Rowlands, 1974) . The mixture was magnetically stirred, portions (2ml) were withdrawn into a fluorimeter cell (path length 1 cm) and the fluorescence intensity measured (excitation 400nm; emission 540nm). The cell's contents (2ml) were returned to the beaker, a known volume of aqueous glycosaminoglycan was added and the procedure repeated. The fluorescence of free Acridine Orange was taken as 100% and subsequent fluorescence intensity readings were related to this. The P/D ratio (polyanion/dye) could be calculated, since the concentrations of the dye and polyanion during the titration were known. A more accurate estimate of the end point was obtained by extrapolation ( Fig. 1) .
Experimental
For the titration in the presence of salts the initial solution was a 1:1 (1pOpM) complex between Acridine
Orange and heparin. Glycosaminoglycans in urine samples were determined in a 20-fold dilution of the original urine, and also after dialysis of urine samples against water for 24h. At the equivalence point of the titrations with urine, it was assumed that one dye morecule binds to each anionic site, and by knowing the concentration of dye at the equivalence point, the concentration of urinary glycosaminoglycans present can be calculated. This concentration is expressed in g/anionic site per litre.
Uronic acid was determined after precipitation of glycosaminoglycans with cetylpyridinium chloride (Di Ferrante, 1967) by use of the modified carbazole test (Bitter & Muir, 1962) . D-Glucuronolactone was used as a standard.
Creatinine was determined by the method of Kayser & Molitor (1956) .
Results
Fig . 1 shows the effect of increasing concentrations of glycosaminoglycans on the-monomeric fluorescence of Acridine Orange. With increasing polyanion concentration, the fluorescence of the free dye decreases and when all the sites of the glycosaminoglycans are occupied by the dye (P/D = 1) the equivalence point is reached. This point was determined by locating the intersection of the two linear sections of the curve.
The effect of increasing concentration of CaCl2 on the electrostatic interaction between Acridine Orange and heparin is shown in Fig. 2 and a limiting salt concentration of 44.2 mM was obtained. Limiting salt concentration values of 480, 465 and 13.3mm were obtained for NH4Cl, NaCl and AIC13 respectively.
Titrations were also performed with the addition of bovine serum albumin to both dye and polyanion. No effect was observed. However, poly-L-arginine and poly-L-lysine, at concentrations of 31.5 and 74.6,UM respectively, completely disrupted the dye- (Beinert, 1960) . This quencher at concentrations above 1 mm had no effect on Acridine Orange fluorescence. Urine terized by excessive excretion of glycosaminoglycans Vol. 175 (Table 1) . The urinary glycosaminoglycans profile can be directly related to the type of mucopolysaccharidosis (McKusick, 1972 ). The glycosaminoglycan assay described here is based on the decrease in monomer fluorescence of purified Acridine Orange that occurs when it binds electrostatically to the anionic sites of the glycosaminoglycan. An Acridine Orange concentration of 10uM was used, since above this value the concentration of dimeric dye and the resultant novel fluorescence increases at the expense of the monomer fluorescence.
Addition of salt to a 1:1 dye-polyanion complex increases the fluorescence intensity as a result of dye displacement, the concentration of salt required completely to disrupt dye-polyanion interaction being termed 'limiting salt concentration' (Jooyandeh et al., 1974; Edwards et al., 1977) . Limiting salt concentration can be directly related to the electropositivity of the cation, and the presence of salt in urine at certain concentrations can affect the titrimetric assay of glycosaminoglycans. Salts can also influence the fluorescence of free Acridine Orange. The initial sharp decrease in the free dye fluorescence (Fig. 2) as cations were added is due to salt-promoted dimer formation, which increased in the order Na+ > NH4+> Ca2+ > Al3+, in agreement with previous findings (Moulik et al., 1976) .
Proteins can effect the interaction between dye and polyanion by (a) masking the anionic sites as a result of electrostatic interaction and/or (b) direct association between the dye and the anionic charges of the protein. Some dyes could also associate with the hydrophobic regions of some proteins, although the polar nature of Acridine Orange does not indicate that this is a major factor in this system. Furthermore, no difference was observed on addition of bovine serum albumin during the titration. However, poly-L-lysine and poly-L-arginine displaced Acridine Orange from the dye-heparin complex and the degree of displacement can be related to the variation in the cationic charge distribuation of these two polypeptides. This strong interaction between glycosaminoglycans and polycations does not have a parallel in urinary proteins. Whiteman (1973b) show that, at the concentrations present in urine of normal subjects, no quenching of Acridine Orange fluorescence was observed.
The sharp and steady decrease in the relative fluorescence intensity during the titration of the dialysed and non-dialysed urine indicated that salts were not present in concentrations that would interfere with the titration. Therefore, the difference between dialysed and non-dialysed samples is due solely to variation in glycosaminoglycan concentrations. Patients with Sanfilippo syndrome showed an apparent decrease in urinary glycosaminoglycans of 17% and 18.5%, and the patient with Hunter syndrome a decrease of 2.5 %. This indicates the presence of lower-molecular-weight glycosaminoglycans in the urine of patients with Sanfilippo syndrome. The low concentrations of glycosaminoglycans present in the patient with Hunter syndrome is due to the age of the subject. However, when the data are expressed in terms of the creatinine excretion, the expected increase over results for normal subjects was observed (Table 1) . Uronic acid assays support the titrimetric data.
In the present study the concentration of glycosaminoglycans from the titration is expressed in equivalents/anionic site per litre (i.e. the unit weight of glycosaminoglycan per anionic site). For comparison, these concentrations have also been expressed in Table 1 in mg/100ml of urine, based on heparin equivalent weight of 150 (calculated by dividing the molecular weight of a heparin tetramer repeating unit by the number of anionic sites on the unit). Since the type and amount of glycosaminoglycans varies with the urine sample the value of expressing concentration in the latter way is only limited.
Although -mucopolysaccharidoses are clinically diagnosed at an early age, the biochemical tests for urinary glycosaminoglycans are important to assess the enzymic deficiency and changes in glycosaminoglycan excretion after treatment such as fibroblast transplants (Dean et al., 1976) . The analytical technique described here is simple, sensitive and reproducible.
